Product image of Meropenem Aptapharma (Meropenem Trihydrate) supplied by GNH India

Meropenem Aptapharma

Active Ingredient:
Meropenem Trihydrate
Origin:
EU

Meropenem Aptapharma (Meropenem Trihydrate)

Meropenem, the active ingredient in Meropenem Aptapharma, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats serious bacterial infections such as intra‑abdominal, urinary tract, and hospital‑acquired pneumonias in hospitalized patients.
GNH India supplies Meropenem Aptapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Apta Medica Internacional D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Meropenem is a broad‑spectrum carbapenem used to treat severe bacterial infections in the hospital setting.
  • Complicated intra‑abdominal infections: provides rapid bacterial eradication in severe abdominal sepsis.
  • Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis.
  • Hospital‑acquired pneumonia: effective against multidrug‑resistant organisms in lung infections.
  • Ventilator‑associated pneumonia: targets pathogens common in ventilated patients.
  • Septicemia: offers bactericidal activity for bloodstream infections.

How It Works

  • Meropenem binds with high affinity to multiple penicillin‑binding proteins, inhibiting the final stages of bacterial cell wall peptidoglycan synthesis. This disruption leads to cell lysis and death, providing bactericidal activity against a wide range of Gram‑positive and Gram‑negative organisms, including many resistant strains.

Side Effects

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limited.
  • Headache: transient cranial discomfort.
  • Rash: mild skin erythema.
  • Infusion site reactions: pain or erythema at the injection site.
  • Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects

  • Seizures: especially in patients with CNS disorders or renal impairment.
  • Clostridioides difficile‑associated diarrhea: severe colitis risk.
  • Anaphylaxis: acute allergic reaction requiring emergency care.
  • Severe renal toxicity: acute kidney injury in susceptible individuals.
  • Neutropenia: marked reduction in white blood cells.
  • Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Precautions & Warnings

Meropenem should be used with caution in specific clinical situations.

  • Renal impairment: adjust dosage based on creatinine clearance.
  • CNS disorders: monitor for seizures, especially in patients with a history of epilepsy.
  • Hypersensitivity: avoid in patients with known carbapenem or beta‑lactam allergy.
  • Pregnancy and lactation: safety not established; weigh benefits against potential risks.
  • Concomitant nephrotoxic drugs: monitor renal function closely.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropenem may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid)

  • Valproic acid: meropenem can reduce plasma concentrations, increasing seizure risk.
  • Probenecid: may increase meropenem levels, raising toxicity potential.
  • Other carbapenems: concurrent use can amplify adverse effects.

Moderate Interactions (Monitor Closely)

  • Aminoglycosides: combined nephrotoxicity; monitor renal function.
  • Loop diuretics: may enhance renal effects.
  • NSAIDs: increase risk of kidney injury.
  • Warfarin: monitor INR for possible anticoagulant effect changes.
  • Oral contraceptives: possible reduction in efficacy; advise alternative contraception.

Frequently Asked Questions

Meropenem Aptapharma is indicated for severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired and ventilator‑associated pneumonia, and septicemia. It is used in hospitalized patients where broad‑spectrum, bactericidal therapy is required.

Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, leading to weakened cell walls, osmotic instability, and ultimately bacterial cell lysis and death.

The dosage of Meropenem Aptapharma is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and local guidelines. Only a qualified healthcare professional should set the dosing regimen.

Safety data for meropenem in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Use only if the potential benefit justifies the potential risk to the fetus or infant, and after consulting a healthcare provider.

To order, submit an enquiry on the Meropenem Aptapharma product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Meropenem offers a broad spectrum of activity similar to other carbapenems like imipenem and ertapenem, but it has enhanced stability against many beta‑lactamases and a lower risk of seizures compared with imipenem. Choice of agent depends on local resistance patterns, infection site, and patient-specific factors.

Meropenem Aptapharma should be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and do not freeze or shake the solution. Once reconstituted, use according to the manufacturer’s instructions and discard any unused portion after the recommended time.

Meropenem Aptapharma is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional, typically over a 15‑30 minute infusion period, using aseptic technique. The exact infusion rate and duration are determined by the prescribing clinician.

Serious risks include the potential for seizures, especially in patients with renal impairment or pre‑existing CNS disorders, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and significant renal toxicity. Prompt medical attention is required if any of these events occur.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any beta‑lactam antibiotics should avoid this product. Caution is also advised for individuals with severe renal impairment, a history of seizures, or those taking medications that may interact significantly with meropenem.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem Trihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT